Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.
Relating to the contract requirements for a contract between a single source continuum contractor and the Department of Family and Protective Services.
Relating to certain requirements regarding a contract between a single source continuum contractor and the Department of Family and Protective Services.